Alphaviral equine encephalomyelitis (Eastern, Western and Venezuelan)

OIE Revue Scientifique et Technique

Volumn 34, Issue 2, 2015, Pages 491-501

  Arechiga Ceballos N ^a   Aguilar Setien A ^b  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Alphavirus; Eastern equine encephalomyelitis virus; Encephalitis; Equine; Equine encephalomyelitis virus; Horse; Overview; Vector borne; Venezuelan equine encephalomyelitis virus Western equine encephalomyelitis virus Zoonosis

Indexed keywords

ALPHAVIRUS; ALPHAVIRUS INFECTION; ANIMAL; HORSE; HORSE DISEASE; VIROLOGY; WESTERN HEMISPHERE; ZOONOSIS;

ALPHAVIRUS; AMERICAS; ANIMALS; ENCEPHALOMYELITIS, EQUINE; HORSE DISEASES; HORSES; ZOONOSES;

EID: 84945264728     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.34.2.2374     Document Type: Article

References (62)

1. Griffin D.E. (2007).-Alphaviruses. In Fields' virology, 5th Ed. (B.N. Fields, D.M. Knipe & EM. Howley, eds). Lippincott-Raven, New York, 1023-1068.
2. Strauss J.H. & Strauss E.G. (1994).-The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev., 58 (3), 491-562.
3. Pfeffer M. & Dobler G. (2010).-Emergence of zoonotic arboviruses by animal trade and migration. Parasit. Vectors, 3 (1), 35.
4. MacKay R.J. (2009).-Alphaviral encephalomyelitis (EEE, WEE and VEE). In Infectious diseases of the horse (T.S. Mair & R.E. Hutchinson, eds). Equine Veterinary Journal Ltd, Cambridgeshire, United Kingdom, 95-108.
5. Minke J.M., Audonnet J.C. & Fischer L. (2004).-Equine viral vaccines: the past, present and future. Vet. Res., 35 (4), 425-443.
6. Center for Food Security and Public Health (2008).-Eastern equine encephalomyelitis, Western equine encephalomyelitis and Venezuelan equine encephalomyelitis. College of Veterinary Medicine, Iowa State University, Ames, Iowa, 1-10.
7. MacLachlan NJ. & Dubovi E.J. (2010).-Togaviridae. In Fenner's veterinary virology, 4th Ed. (NJ. MacLachlan & E.J. Dubovi, eds). Academic Press, London, 456-464.
8. Gibbs E.EJ. & Long M.T. (2007).-Equine alphaviruses. In Equine infectious disease, 1st Ed. (D.C. Sellon & M.T. Long, eds). Saunders, St. Louis, Missouri, 191-197.
9. Steele K.E., Reed D.S., Glass P.J., Hart M.K., Ludwig G.V, Pratt WD., Parker M.D. & Smith J.E (2008).-Alphavirus encephalitis. In Medical aspects of biological warfare (W Reed, ed.). Department of the Army, Arlington, Virginia, 241-270.
10. Taylor K.G. & Paessler S. (2013).-Pathogenesis of Venezuelan equine encephalitis. Vet. Microbiol., 167 (1-2), 145-150. doi:10.1016/j.vetmic.2013.07.012.
11. World Organisation for Animal Health (OIE) (2012).-Chapter 2.5.5. Equine encephalomyelitis (Eastern and Western). In Manual of diagnostic tests and vaccines for terrestrial animals, 7th Ed. OIE, Paris, 852-859. Available at: www.oie. int/fileadmin/Home/eng/Health-standards/tahm/2.05.05-EQUINE-ENCEPH.pdf (accessed on 11 May 2015).
12. Zacks M.A. & Paessler S. (2010).-Encephalitic alphaviruses. Vet. Microbiol, 140 (3-4), 281-286.
13. Weaver S.C, Ferro C, Barrera R., Boshell J. & Navarro J.C. (2004).-Venezuelan equine encephalitis. Annu. Rev. Entomol, 49, 141-174.
14. Walton T.E., Jochim M.M., Barber T.L. & Thompson L.H. (1989).-Cross-protective immunity between equine encephalomyelitis viruses in equids. Am. J. Vet. Res., 50 (9), 1442-1446.
15. Rumenaf ET., Strauss E.G. & Strauss J.H. (1995).-Aura virus is a New World representative of Sindbis-like viruses. Virology, 208 (2), 621-633.
16. Karpf A.R., Lenches E., Strauss E.G., Strauss J.H. & Brown D.T. (1997).-Superinfection exclusion of alphaviruses in three mosquito cell lines persistently infected with Sindbis virus. J. Virol., 71 (9), 7119-7123.
17. Adams A.P., Navarro-Lopez R., Ramirez-Aguilar EJ., Lopez-Gonzalez I., Leal G., Flores-Mayorga J.M., Travassos da Rosa A.R, Saxton-Shaw K.D., Singh A.J., Borland E.M., Powers A.M., Tesh R.B., Weaver S.C. & Estrada-Franco J.G. (2012).-Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010. PLoS Negl. Trop. Dis., 6 (11), el875.
18. Oberste M.S., Schmura S.M, Weaver S.C. & Smith J.F. (1999).-Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico. Am. J. Trop. Med. Hyg, 60 (4), 630-634.
19. Weaver S.C, Powers A.M., Brault A.C. & Barrett A.D. (1999).-Molecular epidemiological studies of veterinary arboviral encephalitides. Vet.J., 157 (2), 123-138.
20. Aguilar P.V, Paessler S, Carrara A.S, Baron S, Poast J, Wang E, Moncayo A.C, Anishchenko M, Watts D, Tesh R.B. & Weaver S.C. (2005).-Variation in interferon sensitivity and induction among strains of Eastern equine encephalitis virus. J. Virol, 79 (17), 11300-11310.
21. Logue CH., Bosio CE, Welte T, Keene KM, Ledermann J.E, Phillips A, Sheahan B.J, Pierro D.J, Marlenee N, Brault A.C, Bosio CM, Singh AJ, Powers A.M. & Olson K.E. (2009).-Virulence variation among isolates of Western equine encephalitis virus in an outbred mouse model. J. Gen. Virol., 90 (Pt 8), 1848-1858.
22. Phillpotts RJ, O'Brien L, Appleton R.E, Carr S. & Bennett A. (2005).-Intranasal immunization with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Vaccine, 23 (13), 1615-1623.
23. Williams A.J, O'Brien L.M, Phillpotts R.J. & Perkins S.D. (2009).-Improved efficacy of a gene optimized adenovirus-based vaccine for Venezuelan equine encephalitis virus. Virol. J, 6, 118.
24. Fine D.L, Roberts B.A, Teehee M.L, Terpening S.J, Kelly CL, Raetz J.L, Baker D.C, Powers A.M. & Bowen R.A. (2007).-Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Vaccine, 25 (10), 1868-1876.
25. Hodgson LA, Ludwig G.V & Smith J.F. (1999).-Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors. Vaccine, 17 (9-10), 1151-1160.
26. Zhang R, Hryc CE, Cong Y, Liu X, Jakana J, Gorchakov R, Baker M.L, Weaver S.C. & Chiu W. (2011).-4.4 Acryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J., 30 (18), 3854-3863. doi:10.1038/emboj.2011.261.
27. Gauci RJ, Wu J.Q, Rayner G.A, Barabe N.D, Nagata LP. & Proll D.E (2010).-Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination. Clin. Vaccine Immunol, 17 (1), 176-179.
28. Netolitzky D.J, Schmaltz EL, Parker M.D, Rayner G.A, Fisher G.R, Trent D.W, Bader D.E. & Nagata L.R (2000).-Complete genomic RNA sequence of Western equine encephalitis virus and expression of the structural genes. J. Gen. Virol, 81 (Pt1), 151-159.
29. Das D, Gares S.L, Nagata LE & Suresh M.R. (2004).-Evaluation of a Western equine encephalitis recombinant El protein for protective immunity and diagnostics. Antiviral Res., 64 (2), 85-92.
30. Das D, Nagata LE & Suresh M.R. (2007).-Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus. Virus Res, 128 (1-2), 26-33.
31. Hu WG, Chau D, Wong C, Masri S.A., Fulton R.E. & Nagata L.R (2008).-Cloning, expression and purification of envelope proteins El and E2 of Western equine encephalitis virus and potential use of them as antigens in immunoassays. Vet. Microbiol, 128 (3-4), 374-379.
32. Meyer K.E, Haring CM. & Howitt B. (1931).-The etiology of epizootic encephalomyelitis of horses in the San Joaquin Valley. Science, 74 (1913), 227-228. doi:10.1126/science.74.1913.227.
33. Hahn C.S, Lustig S, Strauss E.G. & Strauss J.H. (1988).-Western equine encephalitis virus is a recombinant virus. Proc. NatlAcad. Sci. USA, 85 (16), 5997-6001.
34. Weaver S.C, Kang W, Shirako Y, Rumenapf T, Strauss E.G. & Strauss J.H. (1997).-Recombinational history and molecular evolution of Western equine encephalomyelitis complex alphaviruses. J. Virol, 71 (1), 613-623.
35. Bergren N.A, Auguste A.J, Forrester N.L, Negi S.S, Braun WA. & Weaver S.C. (2014).-Western equine encephalitis virus: evolutionary analysis of a declining alphavirus based on complete genome sequences. J. Virol, 88 (16), 9260-9267. doi:10.1128/JVI.01463-14.
36. Delfraro A, Burgueño A, Morel N, Gonzàlez G, Garcia A, Morelli J, Pérez W, Chiparelli H. & Arbiza J. (2011).-Fatal human case of Western equine encephalitis, Uruguay. Emerg. Infect. Dis, 17 (5), 952-954. doi:10.3201/eidl705.101068.
37. Steele K.E. & Twenhafel N.A. (2010).-Review paper: pathology of animal models of alphavirus encephalitis. Vet.Pathol.,47(5), 790-805.doi:10.1177/0300985810372508.
38. Gilmer L.T. & Shahan M.S. (1933).-The 1933 outbreak of infectious equine encephalomyelitis in the eastern states. N. Am. Vet., 14, 25-27.
39. TenBroeck C. & Merrill M.H. (1933).-A serological difference between Eastern and Western equine encephalomyelitis virus. Proc. Soc. Experim. Biol. Med., 31, 217-220.
40. Lindsey N.E, Lehman J.A, Staples J.E. & Fischer M.; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Frevention (CDC) (2014).-West Nile virus and other arboviral diseases-United States, 2013. MMWR, 63 (24), 521-526.
41. Armstrong P.M. & Andreadis T.G. (2013).-Eastern equine encephalitis virus-old enemy, new threat. N. Engl. J. Med, 368 (18), 1670-1673. doi:10.1056/NEJMpl213696.
42. Carrera J.E, Forrester N., Wang E., Vittor A.Y., Haddow A.D., Lopez-Vergès S., Abadía L, Castaño E., Sosa N., Bàez C, Estripeaut D., Díaz Y., Beltràn D., Cisneros J., Cedeño H.G., Travassos da Rosa A.P., Hernandez H., Martínez-Torres A.O., Tesh R.B. & Weaver S.C. (2013).-Eastern equine encephalitis in Latin America. N. Engl. J. Med., 369 (8), 732-744. doi:10.1056/NEJMoal212628.
43. Deresiewicz R.L., Thaler S.J., Hsu L. & Zamani A.A. (1997).-Clinical and neuroradiographic manifestations of Eastern equine encephalitis. N. Engl. J. Med., 336 (26), 1867-1874.
44. Wang E., Petrakova O., Adams A.P., Aguilar EV, Kang W, Paessler S., Volk S.M., Frolov I. & Weaver S.C. (2007).-Sindbis/Eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine, 25 (43), 7573-7581.
45. Kenney J.L., Adams A.P. & Weaver S.C. (2010).-Transmission potential of two chimeric Western equine encephalitis vaccine candidates in Culex tarsalis. Am. J. Trop. Med. Hyg., 82 (2), 354-359. doi:10.4269/ajtmh.2010.09-0092.
46. Turell M.J., Ludwig G.V, KondigJ. & Smith J.E (1999).-Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates. Am. J. Trop. Med. Hyg., 60 (6), 1041-1044.
47. Rossi S.L., Guerbois M., Gorchakov R., Plante K.S., Forrester N.L.&WeaverS.C.(2013).-IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. Virology, 437 (2), 81-88.
48. Dupuy L.C., Locher CE, Paidhungat M., Richards M.J., Lind CM., Bakken R., Parker M.D., Whalen R.G. & Schmaljohn C.S. (2009).-Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Vaccine, 27 (31), 4152-4160.
49. Paessler S., Fayzulin R.Z., Anishchenko M., Greene LE, Weaver S.C. & Frolov I. (2003).-Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J. Virol., 77 (17), 9278-9286.
50. Reed D.S., Lind CM., Lackemeyer M.G., Sullivan L.J., Pratt WD. & Parker M.D. (2005).-Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine, 23 (24), 3139-3147.
51. Nagata LP., Hu WG, Masri S.A., Rayner G.A., Schmaltz EL, Das D., Wu J., Long M.C., Chan C, Proll D., JagerS.Jebailey L, SureshM.R. & WongJ.P. (2005).-Efficacy of DNA vaccination against Western equine encephalitis virus infection. Vaccine, 23 (17-18), 2280-2283.
52. Garmashova N., Atasheva S., Kang W, Weaver S.C, Frolova E. & Frolov I. (2007).-Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J. Virol., 81, 13552-13565.
53. Aguilar P.V., Weaver S.C. & Basler CE (2007).-Capsid protein of Eastern equine encephalitis virus inhibits host cell gene expression. J. Virol., 81 (24), 3866-3876.
54. Schoepp R.J., Smith J.E & Parker M.D. (2002).-Recombinant chimeric Western and Eastern equine encephalitis viruses as potential vaccine candidates. Virology, 302 (2), 299-309.
55. Davis N.L., Brown K.W, Greenwald G.E, Zajac A.J., Zacny V.L., Smith J.E & Johnston R.E. (1995).-Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in El. Virology, 212(1), 102-110.
56. Hart M.K., Lind C, Bakken R., Robertson M., Tammariello R. & Ludwig G.V (2001).-Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine, 20 (3,4), 616-622.
57. Sun C, Gardner C.L., Watson A.M., Ryman K.D. & Klimstra WB. (2014).-Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J. Virol., 88 (4), 2035-2046. doi:10.1128/JVI.02990-13.
58. Schmaljohn A.L., Johnson E.D., Dalrymple J.M. & Cole G.A. (1982).-Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature, 297 (5861), 70-72.
59. Tatsis N. & Erlt H.C.J. (2004).-Adenoviruses as vaccine vectors. Molec. Ther., 10 (4), 616-629.
60. Saade F. & Petrovsky N. (2012).-Technologies for enhanced efficacy of DNA vaccines. Expert Rev. Vaccines, 11 (2), 189-209.
61. Li L., Saade E & Petrovsky N. (2012).-The future of human DNA vaccines. J. Biotechnol., 162 (2-3), 171-182.
62. Porta J., Jose J., Roehrig J.T., Blair CD., Kuhn R.J. & Rossmann M.G. (2014).-Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies. J. Virol., 88 (17), 9616-9623.